Diabeto Medtech India Private Limited
Diabeto Medtech India Private Limited is a Private Company limited by Shares company incorporated in 2014 and based in Maharashtra, India. Diabeto Medtech India Private Limited operates in Software publishing, consultancy and supply [Software publishing includes produc (NIC 72200) with authorized capital of ₹5.00 L and paid-up capital of ₹1.00 L. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
Diabeto - Domain name services providing resources and information for domain owners. Raised a total funding of $65K over 2 rounds from 3 investors.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Diabeto Medtech India Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 27 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +6d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Diabeto Medtech India Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 673601043 | HDFC Bank Ltd(Bank) | ₹7.64 Cr | 19 Sep 2020 | Open |
| 667079557 | Kotak Mahindra Bank Ltd(Bank) | ₹23.61 Cr | 19 Sep 2022 | Satisfied |
| 246855500 | Axis Bank Ltd(Bank) | ₹12.00 Cr | 19 Sep 2023 | Satisfied |
| 706954212 | HDFC Bank Ltd(Bank) | ₹7.77 Cr | 19 Sep 2023 | Satisfied |
| 485110663 | HDFC Bank Ltd(Bank) | ₹9.73 Cr | 27 Jan 2022 | Open |
Charge IDs, lenders & amounts for Diabeto Medtech India Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹38.52 Cr | ₹1.32 Cr | ₹27.78 Cr | ₹42.91 Cr | 240 |
| FY2023-24 | ₹34.32 Cr | ₹59.09 L | ₹17.07 Cr | ₹45.91 Cr | 192 |
| FY2022-23 | ₹29.75 Cr | ₹31.03 L | ₹24.98 Cr | ₹38.17 Cr | 276 |
| FY2021-22 | ₹25.08 Cr | ₹90.81 L | ₹21.96 Cr | ₹36.15 Cr | 46 |
Audited financials & ratios for Diabeto Medtech India Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹38.52 Cr | ₹34.32 Cr | ₹29.75 Cr | ₹25.08 Cr |
| Other income | ₹1.47 Cr | ₹24.45 L | ₹96.17 L | ₹41.68 L |
| Total income | ₹39.99 Cr | ₹34.57 Cr | ₹30.71 Cr | ₹25.50 Cr |
| Total expenses | ₹38.31 Cr | ₹33.81 Cr | ₹30.32 Cr | ₹24.34 Cr |
| Profit before tax | ₹1.71 Cr | ₹76.82 L | ₹40.34 L | ₹1.18 Cr |
| Profit / (Loss) after tax | ₹1.32 Cr | ₹59.09 L | ₹31.03 L | ₹90.81 L |
| Balance sheet | ||||
| Equity / Net worth | ₹27.78 Cr | ₹17.07 Cr | ₹24.98 Cr | ₹21.96 Cr |
| Borrowings | ₹6.59 Cr | ₹9.13 Cr | ₹4.61 Cr | ₹2.84 Cr |
| Current liabilities | ₹8.49 Cr | ₹13.65 Cr | ₹7.20 Cr | ₹5.53 Cr |
| Total liabilities | ₹15.13 Cr | ₹28.85 Cr | ₹13.19 Cr | ₹14.20 Cr |
| Current assets | ₹19.63 Cr | ₹17.97 Cr | ₹19.56 Cr | ₹18.57 Cr |
| Cash & equivalents | ₹6.48 Cr | ₹5.04 Cr | ₹6.51 Cr | ₹5.85 Cr |
| Total assets | ₹42.91 Cr | ₹45.91 Cr | ₹38.17 Cr | ₹36.15 Cr |
| Employees | 240 | 192 | 276 | 46 |
Audited financials & ratios for Diabeto Medtech India Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹38.52 Cr | +33.5% | +9.7% | +18.2% |
| Profit after Tax | ₹1.32 Cr | +10.1% | -4.2% | +6.7% |
| Net Worth | ₹27.78 Cr | +29.2% | +27.5% | +1.4% |
| Employees | 240 | +31.3% | +13.2% | +10.7% |
Audited financials & ratios for Diabeto Medtech India Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹38.52 Cr | ₹1.32 Cr | +3.42% | +33.08% | +4.74% | +3.07% | 0.24 | ₹16.05 L |
| FY2023-24 | ₹34.32 Cr | ₹59.09 L | +1.72% | +38.52% | +3.46% | +1.29% | 0.53 | ₹17.88 L |
| FY2022-23 | ₹29.75 Cr | ₹31.03 L | +1.04% | -7.99% | +1.24% | +0.81% | 0.18 | ₹10.78 L |
| FY2021-22 | ₹25.08 Cr | ₹90.81 L | +3.62% | -11.02% | +4.14% | +2.51% | 0.13 | ₹54.53 L |
Audited financials & ratios for Diabeto Medtech India Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 1,15,40,661 | 83.32% |
| Institutional Investors | 3 | 7,40,790 | 5.35% |
| Public & Others | 11 | 15,69,870 | 11.33% |
Promoter, institutional & public holding for Diabeto Medtech India Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
105 peersTop 10 in Software publishing, consultancy and supply [Software publishing includes produc
by healthView all ›Events & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.